Keywords
Last Name
Institution

Joseph F. John

Title
InstitutionMedical University of South Carolina
DepartmentInfectious Diseases
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Prabakar J, John J, Arumugham IM, Kumar RP, Sakthi DS. Comparing the Effectiveness of Probiotic, Green Tea, and Chlorhexidine- and Fluoride-containing Dentifrices on Oral Microbial Flora: A Double-blind, Randomized Clinical Trial. Contemp Clin Dent. 2018 Oct-Dec; 9(4):560-569. PMID: 31772463.
      View in: PubMed
    2. Schmidt MG, Salgado CD, Freeman KD, John JF, Cantey JR, Sharpe PA, Michels HT. Antimicrobial surfaces to prevent healthcare-associated infections: a systematic review - a different view. J Hosp Infect. 2018 07; 99(3):309-311. PMID: 29448050.
      View in: PubMed
    3. John JF. EDITORIAL. J S C Med Assoc. 2015 Dec-2016 Jan; 111(4):114. PMID: 27141700.
      View in: PubMed
    4. John JF. Violence Starting but Not Ending in the Home. J S C Med Assoc. 2015 Sep-Oct; 111(3):79. PMID: 27132339.
      View in: PubMed
    5. John JF. The Forum for South Carolina Physicians. J S C Med Assoc. 2015 Jun; 111(2):44. PMID: 27132329.
      View in: PubMed
    6. Salgado CD, Sepkowitz KA, John JF, Cantey JR, Attaway HH, Freeman KD, Sharpe PA, Michels HT, Schmidt MG. Reply to Harbarth et al. Infect Control Hosp Epidemiol. 2013 Sep; 34(9):997-9. PMID: 23917920.
      View in: PubMed
    7. John JF, Steed LL. Antibiotic resistance: a clinical danger beyond 2013. J S C Med Assoc. 2013 Jun; 109(2):54-8. PMID: 24902392.
      View in: PubMed
    8. Salgado CD, Sepkowitz KA, John JF, Cantey JR, Attaway HH, Freeman KD, Sharpe PA, Michels HT, Schmidt MG. Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit. Infect Control Hosp Epidemiol. 2013 May; 34(5):479-86. PMID: 23571364.
      View in: PubMed
    9. Ito T, Hiramatsu K, Tomasz A, de Lencastre H, Perreten V, Holden MT, Coleman DC, Goering R, Giffard PM, Skov RL, Zhang K, Westh H, O'Brien F, Tenover FC, Oliveira DC, Boyle-Vavra S, Laurent F, Kearns AM, Kreiswirth B, Ko KS, Grundmann H, Sollid JE, John JF, Daum R, Soderquist B, Buist G. Guidelines for reporting novel mecA gene homologues. Antimicrob Agents Chemother. 2012 Oct; 56(10):4997-9. PMID: 22869575.
      View in: PubMed
    10. Schmidt MG, Attaway HH, Sharpe PA, John J, Sepkowitz KA, Morgan A, Fairey SE, Singh S, Steed LL, Cantey JR, Freeman KD, Michels HT, Salgado CD. Sustained reduction of microbial burden on common hospital surfaces through introduction of copper. J Clin Microbiol. 2012 Jul; 50(7):2217-23. PMID: 22553242.
      View in: PubMed
    11. John JF, Baker JM, Fraggos M, Adams C, Hutchison F. All hazards planning and response in the Veterans Administration. J S C Med Assoc. 2011 Jun; 107(3):99-100. PMID: 22057713.
      View in: PubMed
    12. John JF, Lindsay JA. Clones and drones: do variants of Panton-Valentine leukocidin extend the reach of community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis. 2008 Jan 15; 197(2):175-8. PMID: 18177251.
      View in: PubMed
    13. John JF, Harvin AM. History and evolution of antibiotic resistance in coagulase-negative staphylococci: Susceptibility profiles of new anti-staphylococcal agents. Ther Clin Risk Manag. 2007 Dec; 3(6):1143-52. PMID: 18516271.
      View in: PubMed
    14. John JF. Drug evaluation: tefibazumab--a monoclonal antibody against staphylococcal infection. Curr Opin Mol Ther. 2006 Oct; 8(5):455-60. PMID: 17078388.
      View in: PubMed
    15. Weems JJ, Steinberg JP, Filler S, Baddley JW, Corey GR, Sampathkumar P, Winston L, John JF, Kubin CJ, Talwani R, Moore T, Patti JM, Hetherington S, Texter M, Wenzel E, Kelley VA, Fowler VG. Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2006 Aug; 50(8):2751-5. PMID: 16870768.
      View in: PubMed
    16. Louie TJ, Peppe J, Watt CK, Johnson D, Mohammed R, Dow G, Weiss K, Simon S, John JF, Garber G, Chasan-Taber S, Davidson DM. Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea. Clin Infect Dis. 2006 Aug 15; 43(4):411-20. PMID: 16838228.
      View in: PubMed
    17. Majeski JA, John JF. Necrotizing soft tissue infections: a guide to early diagnosis and initial therapy. South Med J. 2003 Sep; 96(9):900-5. PMID: 14513988.
      View in: PubMed
    18. Nahvi MD, Fitzgibbon JE, John JF, Dubin DT. Sequence analysis of dru regions from methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococcal isolates. Microb Drug Resist. 2001; 7(1):1-12. PMID: 11310798.
      View in: PubMed
    19. Roberts RB, Chung M, de Lencastre H, Hargrave J, Tomasz A, Nicolau DP, John JF, Korzeniowski O. Distribution of methicillin-resistant Staphylococcus aureus clones among health care facilities in Connecticut, New Jersey, and Pennsylvania. . Microb Drug Resist. 2000; 6(3):245-51. PMID: 11144425.
      View in: PubMed
    20. John JF, Rice LB. The microbial genetics of antibiotic cycling. Infect Control Hosp Epidemiol. 2000 Jan; 21(1 Suppl):S22-31. PMID: 10654632.
      View in: PubMed
    21. Dubin DT, Fitzgibbon JE, Nahvi MD, John JF. Topoisomerase sequences of coagulase-negative staphylococcal isolates resistant to ciprofloxacin or trovafloxacin. Antimicrob Agents Chemother. 1999 Jul; 43(7):1631-7. PMID: 10390214.
      View in: PubMed
    22. Fitzgibbon JE, John JF, Delucia JL, Dubin DT. Topoisomerase mutations in trovafloxacin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1998 Aug; 42(8):2122-4. PMID: 9687420.
      View in: PubMed
    23. Shlaes DM, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997 Sep; 25(3):584-99. PMID: 9314444.
      View in: PubMed
    24. Shlaes DM, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol. 1997 Apr; 18(4):275-91. PMID: 9131374.
      View in: PubMed
    25. Donta ST, Peduzzi P, Cross AS, Sadoff J, Haakenson C, Cryz SJ, Kauffman C, Bradley S, Gafford G, Elliston D, Beam TR, John JF, Ribner B, Cantey R, Welsh CH, Ellison RT, Young EJ, Hamill RJ, Leaf H, Schein RM, Mulligan M, Johnson C, Abrutyn E, Griffiss JM, Slagle D, et al. Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group. J Infect Dis. 1996 Sep; 174(3):537-43. PMID: 8769611.
      View in: PubMed
    26. Bratoeva MP, John JF. In vivo R-plasmid transfer in a patient with a mixed infection of shigella dysentery. Epidemiol Infect. 1994 Apr; 112(2):247-52. PMID: 8149999.
      View in: PubMed
    27. John JF, Grieshop TJ, Atkins LM, Platt CG. Widespread colonization of personnel at a Veterans Affairs medical center by methicillin-resistant, coagulase-negative Staphylococcus. Clin Infect Dis. 1993 Sep; 17(3):380-8. PMID: 8105982.
      View in: PubMed
    28. Walsh TJ, Standiford HC, Reboli AC, John JF, Mulligan ME, Ribner BS, Montgomerie JZ, Goetz MB, Mayhall CG, Rimland D, et al. Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome. Antimicrob Agents Chemother. 1993 Jun; 37(6):1334-42. PMID: 8328783.
      View in: PubMed
    29. Mulligan ME, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA, Kauffman CA, Yu VL. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med. 1993 Mar; 94(3):313-28. PMID: 8452155.
      View in: PubMed
    30. Montgomerie JZ, John JF, Atkins LM, Gilmore DS, Ashley MA. Increased frequency of large R-plasmids in Klebsiella pneumoniae colonizing patients with spinal cord injury. Diagn Microbiol Infect Dis. 1993 Jan; 16(1):25-9. PMID: 8381063.
      View in: PubMed
    31. Patrick CH, John JF, Levkoff AH, Atkins LM. Relatedness of strains of methicillin-resistant coagulase-negative Staphylococcus colonizing hospital personnel and producing bacteremias in a neonatal intensive care unit. Pediatr Infect Dis J. 1992 Nov; 11(11):935-40. PMID: 1454435.
      View in: PubMed
    32. John JF, Atkins LT, Maple PA, Bratoeva M. Activities of newer fluoroquinolones against Shigella sonnei. Antimicrob Agents Chemother. 1992 Oct; 36(10):2346-8. PMID: 1444317.
      View in: PubMed
    33. Bratoeva MP, John JF, Barg NL. Molecular epidemiology of trimethoprim-resistant Shigella boydii serotype 2 strains from Bulgaria. J Clin Microbiol. 1992 Jun; 30(6):1428-31. PMID: 1624559.
      View in: PubMed
    34. Singh M, John JF. Isomeric DNA ladder formation of a plasmid encoding tobramycin resistance from Escherichia coli. J Antimicrob Chemother. 1991 Nov; 28(5):627-37. PMID: 1685732.
      View in: PubMed
    35. Bank HL, John JF, Atkins LM, Schmehl MK, Dratch RJ. Bactericidal action of modulated ultraviolet light on six groups of Salmonella. Infect Control Hosp Epidemiol. 1991 Aug; 12(8):486-9. PMID: 1918893.
      View in: PubMed
    36. John JF, Ribner BS. Antibiotic resistance in long-term care facilities. Infect Control Hosp Epidemiol. 1991 Apr; 12(4):245-50. PMID: 1905739.
      View in: PubMed
    37. Reboli AC, John JF, Platt CG, Cantey JR. Methicillin-resistant Staphylococcus aureus outbreak at a Veterans' Affairs Medical Center: importance of carriage of the organism by hospital personnel. Infect Control Hosp Epidemiol. 1990 Jun; 11(6):291-6. PMID: 2373851.
      View in: PubMed
    38. Bratoeva MP, John JF. Dissemination of trimethoprim-resistant clones of Shigella sonnei in Bulgaria. J Infect Dis. 1989 Apr; 159(4):648-53. PMID: 2647861.
      View in: PubMed
    39. Reboli AC, John JF, Levkoff AH. Epidemic methicillin-gentamicin-resistant Staphylococcus aureus in a neonatal intensive care unit. Am J Dis Child. 1989 Jan; 143(1):34-9. PMID: 2910044.
      View in: PubMed
    40. John JF. What price success? The continuing saga of the toxic:therapeutic ratio in the use of aminoglycoside antibiotics. J Infect Dis. 1988 Jul; 158(1):1-6. PMID: 3292658.
      View in: PubMed
    41. John JF, Reboli AC. MRSA colonization. Infect Control. 1987 Nov; 8(11):445-6. PMID: 3429154.
      View in: PubMed
    42. Del Bene VE, John JF, Twitty JA, Lewis JW. Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance. J Infect Dis. 1986 Aug; 154(2):349-52. PMID: 2941491.
      View in: PubMed
    43. Bryan CS, Ervin FR, John JF, Richards VR. Cost-effective antimicrobial therapy: an approach for physicians and community hospitals. J S C Med Assoc. 1986 Mar; 82(3):121-248. PMID: 3084868.
      View in: PubMed
    44. Bryan CS, John JF, Pai MS, Austin TL. Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance. Am J Dis Child. 1985 Nov; 139(11):1086-9. PMID: 3904403.
      View in: PubMed
    45. Newport MT, John JF, Michel YM, Levkoff AH. Endemic Serratia marcescens infection in a neonatal intensive care nursery associated with gastrointestinal colonization. Pediatr Infect Dis. 1985 Mar-Apr; 4(2):160-7. PMID: 3885179.
      View in: PubMed
    46. John JF, Twitty JA. Amifloxacin activity against well-defined gentamicin-resistant, gram-negative bacteria. Antimicrob Agents Chemother. 1984 Nov; 26(5):781-4. PMID: 6440481.
      View in: PubMed
    47. John JF, McNeill WF. Characteristics of Serratia marcescens containing a plasmid coding for gentamicin resistance in nosocomial infections. J Infect Dis. 1981 Jun; 143(6):810-7. PMID: 7019356.
      View in: PubMed
    48. John JF, McNeill WF. Activity of cephalosporins against methicillin-susceptible and methicillin-resistant, coagulase-negative staphylococci: minimal effect of beta-lactamase. Antimicrob Agents Chemother. 1980 Feb; 17(2):179-83. PMID: 6966906.
      View in: PubMed
    49. John JF, Rubens CE, Farrar WE. Characteristics of gentamicin resistance in nosocomial infections. Am J Med Sci. 1980 Jan-Feb; 279(1):25-30. PMID: 6768292.
      View in: PubMed
    50. John JF, Gramling PK, O'Dell NM. Species identification of coagulase-negative staphylococci from urinary tract isolates. J Clin Microbiol. 1978 Oct; 8(4):435-7. PMID: 363741.
      View in: PubMed
    51. John JF. Nosocomial infection rates at a General Army Hospital. Am J Surg. 1977 Sep; 134(3):381-4. PMID: 900340.
      View in: PubMed
    52. John JF. Trimethoprim-sulfamethoxzole: a rational antibiotic combination with many potential indications. J S C Med Assoc. 1976 Jul; 72(7):264-5. PMID: 1067463.
      View in: PubMed
    John's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description